A Patient-centered Approach to Managing Patients with Type 2 Diabetes       2.00 AMA PRA Category 1 Credit(s)™   |   2.0 contact hours
Despite the availability of a number of therapeutic options, management of type 2 diabetes (T2DM) and hyperglycemia remains suboptimal. Evidence shows that physicians are not adequately individualizing incretin-based therapies as there is lack of clear understanding of the similarities and differences between various incretin-based therapies....

A 2014 Update on the Management of Patients with Systemic Lupus Erythematosus     1.50 AMA PRA Category 1 Credit(s)™   |   1.5 contact hours

Systemic lupus erythematosus (SLE) is a chronic, relapsing autoimmune disease of the connective tissues, primarily affecting the skin, kidneys, heart, lungs, nervous system, blood, and joints. SLE is characterized by cytokine dysregulation, polyclonal B-cell activation, autoantibody production, and increased immune complex formation due to...

Recent studies have changed the landscape and thinking on anticoagulation management and stroke prevention in patients with cardiac disease. Therapeutic options now include agents with unique modes of action and exciting new data on patient outcomes. This CME initiative will educate healthcare providers on the current applications of oral...

Advances in the Management of Patients with Rheumatoid Arthritis

1.00 AMA PRA Category 1 Credit(s)™

The management of patients with rheumatoid arthritis actively evolves as further evidence-based data becomes available. The relatively recent development of biologics and DMARDS has presented new challenges in clinical decision making for the busy rheumatologist. This program is designed to provide a review of immunology science which is necessary...
With the advent of JAK2 inhibitors, viable, clinically important treatment options are now becoming available and there is a clear need for focused educational efforts on the diagnosis and prognostic risk-based treatment approaches to myelofibrosis. This unique webcast will be led and developed by a panel of expert physicians who specialize in...

Strategies to Improve Outcomes in Patients with Overactive Bladder

2.00 AMA PRA Category 1 Credit(s)™

Overactive bladder is a unique, symptom-based condition within the field of urology. Recently, the American Urological Association (AUA) released assessment and treatment recommendations for overactive bladder.

Emerging Science and Therapies in Non-small Cell Lung Cancer: Targeting the MET Pathway

2.0 AMA PRA Category 1 Credit(s)™

Over the past decade, research has evolved in the science of identifying targeted biological changes in DNA and individual cancer cells.  Along with the advanced understanding of lung cancer mutations, has come the development of specific targeted therapies that improve patient outcomes.

The pathobiology of myelofibrosis continues to advance and the current understanding of myelofibrosis is complex. Guidelines and recommendations for the diagnosis of myelofibrosis, including the revised WHO criteria for myelofibrosis, is controversial. The clinical trial data on JAK2 inhibitor therapeutics has changed the clinical approach to...

Advances in the Management of Patients with Hyponatremia

2.00 AMA PRA Category 1 Credit(s)™
 
This continuing medical education activity represents a comprehensive summary of the diagnosis and treatment of all types of hyponatremia. The expert faculty present specific treatment recommendations according to the extracellular fluid volume status and the specific etiology of the hyponatremia. Rationale for effective treatment strategies are...

Community-Acquired Bacterial Pneumonia: The Emergency Department as a Pivotal Point of Care

1.50 AMA PRA Category 1 Credit(s)™

During this interactive enduring CME activity, (Emergency Department) specialists will discuss common challenges of managing patients with community-acquired bacterial pneumonia (CABP), including the integration of newer agents into the standard anti-infective mix. Decisions made at this pivotal point of care can affect both patient outcomes and hospital financial health.

Perspective on Alzheimer's: Current and Emerging Diagnostics and Therapies Enduring Web Archive

1.25 AMA PRA Category 1 Credit(s)™

In the US, 5.4 million people suffer from Alzheimer's disease (AD). Roughly 96% of these people are 65 or older, and the prevalence of AD in this group is expected to increase 30% by 2025. AD was responsible for 82,435 deaths in 2008 and is currently considered the 6th leading cause of death in the US...

Controversies in the Treatment of Male Hypogonadism

1.00 AMA PRA Category 1 Credit(s)™

This CME program provides urologists and other healthcare providers an awareness of the various conflicting definitions of hypogonadism, screening guidelines, and the clinical data supporting the benefits and relative safety of testosterone replacement therapy.

Breakthrough pain (BTP) occurs in many cancer patients. Often, short-acting opioids do not have the pharmacokinetic profile to match the rapid and unpredictable onset of BTP. With their rapid onset of action, transmucosal immediate-release fentanyl (TIRF) formulations offer distinct advantages in the treatment of BTP; however, the availability of...

A substantial proportion of the rheumatoid arthritis patient population is not only unresponsive to therapy but experiences an unsustained response to treatment. The management of RA actively evolves as further evidence-based data becomes available. This program is designed to improve the educational command of immunology science and how it is...

The challenge of providing uniformly effective rheumatoid arthritis care has thus far defied a simple solution. Variations in care range from the appropriate adjustment or switching of therapy subsequent to increased disease activity to the selection of therapeutic agent chosen following failure. This program is designed to improve the...

At present, the field of multiple sclerosis (MS) research has made remarkable progress revealing innovative agents, both currently approved for treatment and emerging therapies. With the availability of three oral agents, clinical decision-making and therapeutic strategies are increasingly important. This unique webcast includes a panel of expert...

Patients with advancing metastatic breast cancer present the most challenging management decisions for the practicing oncologist. Over recent years, newer data on microtubule dynamics inhibitor therapeutics have shown improved overall survival for patients previously treated with traditional first and second line chemotherapies. This CME program...

Improving Patient Outcomes In Multiple Sclerosis: Clinical Trial Data and Management Strategies

2.00 AMA PRA Category 1 Credit(s)™

The ArcheMedX learning architecture offers participants interaction to achieve a deeper understanding of the content allowing the learner opportunities to sharpen their clinical skills.

A Practical Approach to Current and Emerging Therapies for the Community Neurologist--A Challenging Case PresentationAt present, the field of multiple sclerosis (MS) research has made remarkable progress revealing innovative agents, both currently approved for treatment and emerging therapies, which target specific pathways contributing to...

Novel Therapeutics in Multiple Sclerosis Management: Clinical Applications Multiple sclerosis (MS) affects an estimated 300,000 individuals in the United States. No cure exists and while there is a lack of consensus on management, strategies to modify disease course are available. These strategies involve initiating disease modifying...

Applying Antithrombotic Therapies to Improve Outcomes in Patients with Atrial FibrillationApproximately 15-25%, or 75,000 ischemic strokes are attributed to atrial fibrillation annually within the United States. Atrial fibrillation is the most frequently diagnosed cardiac arrhythmia and affects more than 2.66 million Americans. Moreover, atrial...

Cardiovascular Care for Women: The 10-Q Report and Beyond

2.00 AMA PRA Category 1 Credit(s)™

Cardiovascular Care for Women: The 10-Q Report and BeyondAn American Journal of Cardiology and American Journal of Medicine Multi-Media WebcastAccording to the The National Coalition for Women’s Health Research’s 10Q Report: Advancing women’s heart health through improved research, diagnosis, and treatment published in June 2011...

 

T2DM Treatment Decisions: Practical Strategies for Interdisciplinary Teams

1.50 AMA PRA Category 1 Credit(s)™

This interactive CME activity is designed to improve individual and team-based care, knowledge and skills. By participating, you will hear faculty review thought-provoking concepts that impact the optimal assessment and treatment of Type 2 Diabetes Mellitus (T2DM) so you can better develop individualized treatment plans for your patients.